Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in PerinatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Infant mortality statistics from the 2013 period linked birth/infant death data set.Natl Vital Stat Rep. 2015; 64: 1-30
- Contribution of genetic disorders to neonatal mortality in a regional intensive care setting.Am J Perinatol. 1994; 11: 100-103https://doi.org/10.1055/s-2007-994565
- Peri-mortem evaluation of infants who die without a diagnosis: focus on advances in genomic technology.J Perinatol. 2018; 38: 1125-1134https://doi.org/10.1038/s41372-018-0187-7
- Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities.Genet Med. 2018; 20: 1396-1404https://doi.org/10.1038/gim.2018.17
- Contribution of malformations and genetic disorders to mortality in a children’s hospital.Am J Med Genet A. 2004; 126-A: 393-397https://doi.org/10.1002/ajmg.a.20409
- Birth prevalence of disorders detectable through newborn screening by race/ethnicity.Genet Med. 2012; 14: 937-945https://doi.org/10.1038/gim.2012.76
- Making a genetic diagnosis in a level IV neonatal intensive care unit population: who, when, how, and at what cost?.J Pediatr. 2019; 213: 211-217.e4https://doi.org/10.1016/j.jpeds.2019.05.054
- Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide.J Community Genet. 2018; 9: 387-396https://doi.org/10.1007/s12687-018-0384-2
- Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq project.Am J Hum Genet. 2019; 104: 76-93https://doi.org/10.1016/j.ajhg.2018.11.016
- Genetics and pediatric hospital admissions, 1985 to 2017.Genet Med. 2020; 22: 1777-1785https://doi.org/10.1038/s41436-020-0871-9
- Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.Am J Hum Genet. 2010; 86: 749-764https://doi.org/10.1016/j.ajhg.2010.04.006
- Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.Proc Natl Acad Sci U S A. 2009; 106: 19096-19101https://doi.org/10.1073/pnas.0910672106
- Ten years of next-generation sequencing technology.Trends Genet. 2014; 30: 418-426https://doi.org/10.1016/j.tig.2014.07.001
- Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation.Sci Transl Med. 2019; 11: eaat6177https://doi.org/10.1126/scitranslmed.aat6177
- Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases.J Med Genet. 2019; 56: 783-791https://doi.org/10.1136/jmedgenet-2019-106111
- Detection of long repeat expansions from PCR-free whole-genome sequence data.Genome Res. 2017; 27: 1895-1903https://doi.org/10.1101/gr.225672.117
- Detecting expansions of tandem repeats in cohorts sequenced with short-read sequencing data.Am J Hum Genet. 2018; 103: 858-873https://doi.org/10.1016/j.ajhg.2018.10.015
- Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.NPJ Genom Med. 2018; 3: 16https://doi.org/10.1038/s41525-018-0053-8
- Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic test.Genet Med. 2021; 23: 1689-1696https://doi.org/10.1038/s41436-021-01193-y
- A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.Genet Med. 2016; 18: 1090-1096https://doi.org/10.1038/gim.2016.1
- A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients.Genet Med. 2020; 22: 1986-1993https://doi.org/10.1038/s41436-020-0929-8
- RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit—successes and challenges.Eur J Pediatr. 2019; 178: 1207-1218https://doi.org/10.1007/s00431-019-03399-4
- The impact of rapid exome sequencing on medical management of critically ill children.J Pediatr. 2020; 226: 202-212.e1https://doi.org/10.1016/j.jpeds.2020.06.0201
- Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings.Lancet Respir Med. 2015; 3: 377-387https://doi.org/10.1016/S2213-2600(15)00139-3
- Rapid targeted genomics in critically ill newborns.Pediatrics. 2017; 140: e20162854https://doi.org/10.1542/peds.2016-2854
- Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management.JAMA Pediatr. 2017; 171: e173438https://doi.org/10.1001/jamapediatrics.2017.3438
- The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants.NPJ Genom Med. 2018; 3: 6https://doi.org/10.1038/s41525-018-0045-8
- Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children.J Med Genet. 2018; 55: 721-728https://doi.org/10.1136/jmedgenet-2018-105396
- Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children.Intensive Care Med. 2019; 45: 627-636https://doi.org/10.1007/s00134-019-05552-x
- Rapid whole genome sequencing has clinical utility in children in the PICU.Pediatr Crit Care Med. 2019; 20: 1007-1020https://doi.org/10.1097/PCC.0000000000002056
- Critical trio exome benefits in-time decision-making for pediatric patients with severe Illnesses.Pediatr Crit Care Med. 2019; 20: 1021-1026https://doi.org/10.1097/PCC.0000000000002068
- Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants.NPJ Genom Med. 2020; 5: 1-6https://doi.org/10.1038/s41525-020-0129-0
- Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China.Hum Genet. 2020; 139: 473-482https://doi.org/10.1007/s00439-019-02103-8
- Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs.Lancet Reg Health West Pac. 2020; 1: 100001https://doi.org/10.1016/j.lanwpc.2020.100001
- Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically ill infants in the China neonatal genomes project.Crit Care Med. 2021; https://doi.org/10.1097/CCM.0000000000005052
- Rapid whole genome sequencing impacts care and resource utilization in infants with congenital heart disease.NPJ Genom Med. 2021; 6: 29https://doi.org/10.1038/s41525-021-00192-x
- Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.NPJ Genom Med. 2018; 3: 10https://doi.org/10.1038/s41525-018-0049-4
- Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian public health care system.JAMA. 2020; 323: 1-9https://doi.org/10.1001/jama.2020.7671
- An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm.Am J Hum Genet. 2020; 107: 942-952https://doi.org/10.1016/j.ajhg.2020.10.003
- A prospective study of parental perceptions of rapid whole-genome and -exome sequencing among seriously ill infants.Am J Hum Genet. 2020; 107: 953-962https://doi.org/10.1016/j.ajhg.2020.10.004
- Meeting the challenges of implementing rapid genomic testing in acute pediatric care.Genet Med. 2018; 20: 1554-1563https://doi.org/10.1038/gim.2018.37
- Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2021; : 1-9
Article info
Publication history
Published online: January 21, 2022
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
